ALDX
$7.55
Aldeyra Therapeu
($.41)
(5.15%)
ALDX
Earnings Whisper ®
N/A
1st Quarter March 2023
Consensus:  ($0.30)
Revenue:  N/A
Thursday
Jun 8
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ALDX reports earnings?
Beat
Meet
Miss

Where is ALDX's stock price going from here?
Up
Flat
Down
Stock chart of ALDX
Analysts
Summary of analysts' recommendations for ALDX
Score
Grade
Pivots
Resistance
$8.33
$8.16
$7.86

$7.69

Support
$7.39
$7.22
$6.92
Tweet
Growth
Description
Aldeyra Therapeutics, Inc. is a biotechnology company. The company's products target immune-mediated, inflammatory, orphan, and other diseases. It is developing NS2, a compound that binds and traps free aldehydes. Aldeyra Therapeutics, Inc. is based in Burlington, Massachusetts.
Peers
Regeneron PharmaceuticalsBioMarin PharmaceuticalBristol-Myers SquibbJohnson & JohnsonEli LillyVertex PharmaceuticalsMerck & Co.PfizerArray TechnologiesUltragenyx Pharmaceutical
›